2 months Wedbush Lowers Earnings Estimates for Alto Neuroscience MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) – Research analysts at Wedbush reduced their Q1 2025 earnings estimates for Alto Neuroscience in a research note issued to investors on Wednesday, October 23rd. Wedbush analyst L. Chico now forecasts…
Earnings · Neuroscience · NYSE · Science
X